Deuterium Metabolic Imaging (DMI) – Technical Innovations and (Pre)clinical Applications
Deuterium Metabolic Imaging (DMI) – Technical Innovations and (Pre)clinical Applications

Deuterium Metabolic Imaging (DMI) – Technical Innovations and (Pre)clinical Applications

On Demand Session

Webinar Overview

Dr. Robin de Graaf’s talk on Deuterium Metabolic Imaging (DMI) – Technical Innovations and (Pre)clinical Applications discusses the long-standing goal of non-invasive imaging of metabolic pathways in neurological diseases to monitor disease progression or therapy efficacy. Robin highlights the advantages of DMI over traditional methods like FDG-PET, including its ability to produce high-contrast 3D metabolic maps using deuterium's favorable MR characteristics. The technique has been effectively applied using deuterated substrates to identify abnormal metabolic profiles in various conditions, including high-grade brain tumors and other neurological disorders. Robin also discusses the origins, current state, recent technical innovations, and future (pre)clinical and research outlooks of deuterium-based MR metabolic imaging.

Speaker

Robin A. de Graaf

Professor of Radiology and Biomedical Imaging at Yale University 

Registration

Input value is invalid.

Are you already in contact with your Bruker representative regarding any product inquiries?

We constantly want to improve our service for our customers. In answering the following question you help us to serve your needs even better in the future: What best describes your situation?

To learn how Bruker handles my personal data, please read Bruker´s Privacy Notice and  Terms of Use.

I agree to share my contact details with Bruker Corporation and its affiliates within the Bruker Group for the purpose of proceeding with my registration.

Already registered and lost your invitation link?

Thank you. The invitation link has been resent.